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Abstract
The sodium^proton exchanger is activated by various agonists, including insulin, even in human red blood cell.
MAPKinase, a family of ubiquitous serine/threonine kinases, plays an important role in the signal transduction pathways
which lead to sodium^proton exchanger activation. The aim of our study was to establish the existence of MAPKinase in
human red blood cell and to investigate the effects of its activation by insulin and okadaic acid on the sodium^proton
exchanger. Immunoblot with antiMAPK antibody revealed the presence of two isoforms, p44ERK1 and p42ERK2. Insulin
stimulated MAPKinase activity and increased the phosphorylation of MAPK tyrosine residues, with a peak time between
3 and 5 min. Okadaic acid, an inhibitor of serine/threonine phosphatases, stimulated MAPKinase activity. In the presence of
PD98059, an inhibitor of MEK, the upstream activator of MAPKinase, insulin and okadaic acid failed to stimulate
MAPKinase. Insulin and okadaic acid increased the activity of the sodium^proton exchanger and this effect was abolished by
PD98059. In conclusion, we first describe the presence and activity of MAPKinase in human red blood cell. Furthermore, we
demonstrate that in human red blood cell, insulin modulates the sodium^proton exchanger through MAPKinase
activation. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The sodium^proton exchanger is a plasma mem-
brane glycoprotein which mediates the exchange of
intracellular H for extracellular Na with a 1:1
stoichiometry [1]. Several isoforms of the protein
have been identi¢ed and are designed as NHE-1 to
-5 [2]. The Na/H exchanger isoform 1 (NHE-1) is
an ubiquitous membrane transporter that has an im-
portant role in the regulation of cell pH (pHi), cell
volume and cell proliferation. NHE-1 is activated by
a wide variety of stimuli, including growth factors,
phorbol esters, insulin, hormones, and it is regulated
by several intracellular kinases such as Ca2-calmo-
dulin, cAMP-dependent kinase, protein kinase C and
the mitogen-activated protein kinases (MAPK) [3,4].
The presence of a tightly coupled sodium/hydro-
gen exchange (NHE) has been well documented in
human red blood cells (RBC) [5]. The internal cyto-
solic amino acid sequence of NHE isoform 1 (NHE1)
was demonstrated in human RBC with immunoblot
assay [6]. Other NHE isoforms are not expressed in
human reticulocytes and RBC [7].
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Ceolotto et al. have demonstrated that in human
RBC, NHE is activated by phorbol esters and by
insulin through di¡erent pathways [8]. The phorbol
ester PMA stimulates NHE by activation and trans-
location of PKC from the cytosol to the membrane,
while insulin activates NHE by PKC-independent
mechanisms. Furthermore, immunoprecipitation as-
says of NHE-1 in RBC treated with insulin showed
an increased NHE-1 phosphorylation [9]. However,
the mechanism underlying NHE-1 activation by in-
sulin in RBC is as yet unknown.
Recent studies in vascular smooth muscle cells
(VSMC) [10], in platelets [11], and in lymphoblasts
[12], have shown that MAPK is involved in NHE-1
regulation. MAPK, a family of ubiquitous Ser/Thr
kinases, plays an important role in various signal
transduction pathways, including insulin, growth fac-
tors, tumor promoters, cytokines, osmotic shock and
stress [13]. In mammalian cells, the ¢rst and best
characterized MAPK isoforms are p44ERK1 and
p42ERK2 both of which are essential for intracellular
transduction signals of growth factors and insulin
[14].
Therefore, the purpose of the present study was to
establish the presence of the p44ERK1 and p42ERK2
MAPK isoforms in human RBC, and to describe
their role in the regulation of NHE.
2. Materials and methods
2.1. Subject selection
Blood samples were drawn from 11 healthy, lean,
normotensive subjects, aged 25^45 years, after an
overnight fast.
2.2. Materials
Protease inhibitors, ATP, EDTA, ouabain, nepta-
zane, methazolamide, DIDS, bumetanide, Tris,
MOPS, HEPES, MES, nystatin, dithitheitrol, sodium
dodecyl sulfate, albumin were purchased from Sigma
(St. Louis, MO). MAPK antibodies were purchased
from Santa Cruz Biotechnology. Porcine insulin, re-
agents for the MAPK assay, MAPK-selective sub-
strate were obtained from Calbiochem (La Jolla,
CA). [Q-32P]ATP, nitrocellulose membranes were ob-
tained from Amersham (Buckinghamshire, UK).
Acationox detergent was obtained from American
Scienti¢c Products (Boston, MA). The speci¢c
MEK inhibitor PD98059 and okadaic acid were
from Calbiochem (La Jolla, CA).
2.3. Preparation of red blood cells
Blood was drawn into heparinized tubes and cen-
trifuged at 3000 rpm for 4 min at 4‡C. Plasma and
bu¡y coat were removed by aspiration, and red
blood cells washed three times with ice-cold washing
solution (CWS) that contained (mmol l31) : choline
chloride 149, MgCl2 1, Tris-MOPS 10, pH 7.4 (4‡C).
2.4. Immunoblot analysis of MAPKinase isoforms
Red blood cells were immunoblotted with rabbit
polyclonal antibody against MAPK carboxyl-termi-
nal epitope (residues 349^361). RBC were lysed and
dissolved in Laemmli bu¡er [15]. The proteins from
RBC were separated by electrophoresis through a
10% polyacrylamide gel. Proteins separated on the
gel were electroblotted onto nitrocellulose membrane
in blotting bu¡er containing (mmol l31) : Tris 48,
glycine 39, pH 8.3, 0.037% SDS in 20% (v/v) meth-
anol for 2 h at 100 V in the cold, using a Bio-Rad
Transblot cell. The nitrocellulose membrane was
blocked overnight at 4‡C in phosphate-bu¡ered sal-
ine (PBS) containing 0.05% (v/v) Tween and 5% bo-
vine serum albumin (BSA). The nitrocellulose mem-
branes were exposed to primary antibody (1:1500
dilution) for p44ERK1 and p42ERK2 overnight at
4‡C. The nitrocellulose membranes were washed
(four times for 20 min) with the same bu¡er and
then incubated for 1 h at room temperature with
1:4000 goat anti-rabbit antibody conjugated to
horseradish peroxidase. Membranes were washed
four times with the same bu¡er, and detection was
made using enhanced chemiluminescence system
(ECL, Amersham).
2.5. Immunoblot analysis of tyrosine-phosphorylated
MAPK
MAPK is active when phosphorylated on both
threonine and tyrosine residues. To investigate the
e¡ect of insulin on MAPK activation, we used phos-
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pho-speci¢c MAPK antibody. Washed RBC were
incubated at 37‡C in a incubation medium contain-
ing (mmol l31) : 150 KCl, 1.0 MgCl2, 5.0 glucose,
1.0 CaCl2, 20 Tris-MOPS pH 7.4, albumin 0.1% in
the presence or absence of insulin (100 nM). Lysed
RBC were electroblotted onto nitrocellulose mem-
branes, and then blocked overnight at 4‡C in phos-
phate-bu¡ered saline (PBS) containing 0.05% (v/v)
Tween and 5% bovine serum albumin (BSA), and
then immunoblotted with the phospho-speci¢c
MAPK antibody (1:1000 dilution). This monoclonal
antibody detects only Thr-202^Tyr-204-phospho-
rylated MAPK.
Detection was made with ECL as described earlier.
Blots were scanned and quanti¢ed with a Bio-Rad
Chemiluminescence Molecular Imaging Systems,
and the results were compared to the control read-
ings, on the same blot, set to 100%.
2.6. MAPK activity
The activity of MAPK was assayed by measuring
the rate of [32P]phosphate incorporation from
[Q-32P]ATP using saturating concentrations of the
MAPK-selective substrate APRTPGGRRR, derived
from bovine myelin basic protein [16]. Washed RBC
were incubated for 30 min at 37‡C in an incubation
medium containing (mmol l31) : 150 KCl, 1.0 MgCl2,
5.0 glucose 1.0 CaCl2, 20 Tris-MOPS pH 7.4, albu-
min 0.1% in the presence or absence of 100 WM
PD98059. Thereafter insulin (100 nM for 1, 3, 5,
10 or 15 min) or okadaic acid (1 WM for 20 min)
were added to the incubation medium. Cells were
lysed with 1 ml of lysis bu¡er, containing (mmol
l31) : Tris-HCl 20, EGTA 2, EDTA 2, sodium £uo-
ride 0.1, sodium orthovanadate 1, PMSF 1, aprotinin
20 Wg ml31, leupeptin 20 Wg ml31, pH 7.5) and were
centrifuged at 12 000 rpm for 10 min at 4‡C. The
standard assay mixture (¢nal volume 40 Wl) con-
tained (mmol l31) : Tris-HCl 12.5, pH 7.4, EGTA
2, MgCl2 10, PKI (protein kinase A inhibitor) 50
mg ml31, 0.4 mg ml31 of peptide, and [Q-32P]ATP
(500 000 cpm/10 Wl). Lysates (20^50 Wg of protein)
were added to this mixture. After 15 min of incuba-
tion at 25‡C, the reaction was stopped with 10 Wl of
diluted trichloroacetic acid. A 40-Wl aliquot of the
reaction media was spotted on a phosphocellulose
paper (2.5U2.5 cm) (Whatman P81). The paper
was washed four times for 10 min, with stirring, in
phosphoric acid, dried, and assayed for 32P by scin-
tillation counting. MAPK assay was linear for
20 min.
MAPK activity was calculated as di¡erence be-
tween the 32P incorporation in the presence and in
the absence of substrate. Data were expressed as
pmol of 32P incorporated into peptide per mg of
protein per min.
The protein concentration was measured by the
method of Lowry et al. [17], using bovine serum
albumin as standard.
2.7. Measurement of NHE
NHE was estimated as net Na in£ux driven by an
outward H gradient [8].
2.7.1. Preparation of RBC
Blood was drawn into heparinized tubes and cen-
trifuged at 3000 rpm for 4 min at 4‡C. Plasma and
bu¡y coat were removed by aspiration, and the RBC
washed three times with ice-cold washing solution
(CWS) that contained (mmol l31) : choline chloride
149, MgCl2 1, Tris-MOPS 10, pH 7.4 (4‡C). The
RBC were then resuspended to approximately 50%
hematocrit with CWS. Aliquots of this suspension
were then used for determination of hematocrit, he-
moglobin (optical density at 540 nm), and Na con-
centration (atomic absorption spectrophotometry)
after appropriate dilution with 0.02% Acationox de-
tergent in double-distilled water.
2.7.2. Modi¢cation of cell cation content
The nystatin procedure was used to prepare so-
dium-depleted cells. All solutions were prepared
with deionized, double-distilled water, and the osmo-
larity was checked using a freezing point osmometer.
Washed, packed cells were incubated at 15% hema-
tocrit in cold nystatin loading solution (NLS) con-
taining 40 Wg ml31 nystatin for 20 min at 4‡C and
protected from light. Nystatin was dissolved in di-
methyl sulfoxide (5 mg in 1.3 ml). For Na deple-
tion, NLS contained (mmol l31) : KCl 150, sucrose
50. The cell suspension was then warmed to 37‡C for
5 min, and the red blood cells washed four times with
warm nystatin washing solution (NWS). NWS had
the same composition as the NLS with the pH ad-
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justed to 7.4 with 1 mmol l31 KH2PO2 bu¡er and 10
mmol l31 glucose and 0.1% albumin added. Removal
of nystatin from the membrane was checked in every
experiment by measurements of the passive perme-
ability to Na.
2.7.3. Modi¢cation of RBC pHi
Na-depleted cells (5% hematocrit) were incubated
at 37‡C for 10 min in acid-loading solutions, which
contained (mmol l31) : KCl 170, MgCl2 0.15, oua-
bain 0.1, bumetanide 0.1 (prepared in dimethyl sulf-
oxide), glucose 10, and Tris-MES 20 adjusted to pH
6.0 at 37‡C. The osmolarity of the acid-loading so-
lutions was adjusted to 360 mOsm by the addition of
sucrose. After a 10-min preincubation with the acid-
loading solution, 100 Wmol l31 4,4-diisothiocyanato-
stilbene-2,2-disulfonic acid (DIDS) (to inhibit the
anion exchanger) and 200 Wmol l31 neptazane (to
inhibit carbonic anhydrase) were added to ¢nal con-
centrations of 100 and 200 Wmol l31, to clamp pHi.
The cells were incubated at 37‡C for 20 more min-
utes and then washed three times with ice-cold pH
washing solution containing (mmol l31) : KCl 170,
MgCl2 0.15, sucrose 40. After the ¢nal wash, the cells
were resuspended to approximately 50% hematocrit
with acid washing solution and stored on ice until
used. Aliquots of the cell suspension were used for
determination of hemoglobin, hematocrit, and intra-
cellular Na content. pHi was determined with a pH
electrode in cell lysate made with 4 vols. of 0.02%
Acationox detergent. The cellular Na concentration
was determined by atomic absorption spectropho-
tometry with suitable standards prepared in double-
distilled and deionized water. The cation content of
the acid loaded cells was expressed per liter original
volume, as determined by relating the absorbance at
540 nm of the cell lysate to that of a known volume
of red cells. The cell volume was estimated by com-
paring the hemoglobin per liter of the loaded cells
with that of the fresh cells.
2.7.4. Measurement of net Na+ in£ux by NHE
NHE was estimated as net Na in£ux into Na
depleted, acid loaded cells driven by an outward H
gradient. To this end, initial rates of net Na in£ux
were measured by incubating RBC in two di¡erent
media, one with pHo 8.0 and another with pHo 6.0.
The di¡erence between both media determines the
fraction of Na in£ux driven by an outward H
gradient (i.e. NHE).
The experiment started with the addition of 200 Wl
of a 50% suspension of the acid loaded cells to 2 ml
Na in£ux media preincubated at 37‡C in a shaking
water bath. The Na in£ux media contained (mmol
l31) : NaCl 150, KCl 20, MgCl2 0.15, ouabain 0.1,
neptazane 0.4, glucose 10, sucrose 40, and either
Tris-MOPS 10 (pH 8.0 at 37‡C) or Tris-MES 10
(pH 6.0 at 37‡C), 360 mOsm l31. RBC were added
to pHo 6.0 and pHo 8.0 Na in£ux media. At timed
intervals (1, 6 and 10 min for pHo 8.0 and 1, 10, and
20 min for pHo 6.0) duplicate 250 Wl aliquots were
pipetted into pre-cooled Eppendorf tubes containing
0.4 ml dibutylphthalate oil layered over 0.7 ml in£ux
wash solution. The transport reaction was termi-
nated by immediate centrifugation at 14 000Ug for
10 s at room temperature. The composition of the
in£ux wash solution was (mmol l31) : Choline chlo-
ride 80, KCl 80, MgCl2 0.25, Tris-MOPS 10 (pH 7.4,
at 4‡C), and sucrose 40. The supernatant was care-
fully removed by aspiration and the external surface
of the tubes wiped dry to eliminate Na contamina-
tion. The bottom of the tube, containing the cell
pellet, was then cut o¡ and placed into 1 ml of
0.02% Acationox to lyse the cells. The cell lysates
were vortexed vigorously and centrifuged at
2000Ug for 5 min at 4‡C, and the hemoglobin con-
centration determined after diluting the lysate with
0.02% Acationox. The lysate Na concentration was
determined by atomic absorption spectrophotometry
and the cell Na content calculated by relating the
optical density of the lysate to the hematocrit and
optical density of the fresh cell suspension. Net
Na in£ux was expressed as mmol l31 cell h31.
2.7.5. Insulin, okadaic acid and PD98059 incubation
experiments
To study the e¡ects of insulin, okadaic acid,
PD98059, aliquots of washed RBC were incubated
for 30 min at 37‡C in an incubation medium con-
taining (mmol l31) : 150 KCl, 1.0 MgCl2, 5.0 glucose.
1.0 CaCl2, 20 Tris-MOPS pH 7.4, albumin 0.1%, in
the presence or absence of 100 WM PD98059. Insulin
(100 nM) or okadaic acid (1 WM) were then added to
the incubation medium for 20 min and to each of the
acid loading, sodium depleting and in£ux media. So-
dium depletion, acid load and sodium in£ux were
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conducted according to the same experimental pro-
tocol reported above.
2.8. Statistical analysis
The statistical analysis was performed with non
parametric tests. Linear regression analysis was also
used, when indicated. A P-value 6 0.05 was accepted
as statistically signi¢cant. Data are presented as
mean þ standard error (S.E.M.).
3. Results
3.1. Identi¢cation and activation of MAPK in human
RBC
As shown in Fig. 1, immunoblot analysis revealed
the presence of two characteristic bands of 44 and
42 kDa, respectively, corresponding to p44ERK1 and
p42ERK2 MAPK isoforms.
MAPK is active when both threonine and tyrosine
residues are phosphorylated. To investigate the e¡ect
of insulin on MAPK activation we used a phospho-
speci¢c MAPK antibody. As shown in Fig. 2, the
immunoblot analysis detected the presence of only
one band of 44 kDa, corresponding to the phos-
phorylated MAPK isoform. Quantitative analysis,
performed by scanning densitometry, showed that
exposure of RBC to 100 nM insulin caused a rapid and transient phosphorylation of MAPKinase. The
maximal increase (48 þ 5%, n = 3) occurred at 3 min,
returning to the baseline at 10 min.
We measured MAPK activity in lysates from cells
treated with 100 nM insulin, using a speci¢c peptide
as a substrate. As shown in Fig. 3, the time course
for activation of MAPK by insulin indicated that
MAPK activity peaked within 3^5 min, and reached
baseline at 10 min.
In order to verify the speci¢city of insulin-induced
MAPK activation, the cells were treated for 30 min
with PD98059 (100 WM), the inhibitor of MEK (the
kinase capable of MAPK phosphorylation and acti-
vation), before being stimulated by insulin. PD98059
completely abolished the e¡ect of insulin on MAPK
activity (Fig. 4).
Similar responses were found in RBC treated for
20 min with 1 WM okadaic acid, a serine/threonine
phosphatase inhibitor. As shown in Fig. 5, okadaic
Fig. 2. Immunoblot analysis of phosphorylated-MAPK in the
presence of insulin (100 nM) in human red blood cells. The
upper panel shows a representative immunoblot with phospho-
speci¢c MAPK antibody at control and after 3, 5, 10 min of
insulin exposure. The lower graph illustrates the quantitative
analysis, performed by scanning densitometry (mean þ S.E.,
n = 3) expressed as percent of control (taken as 100%).
**P6 0.01 versus control.
Fig. 1. Immunoblot of MAPK in human red blood cells. The
¢rst lane (M) is the MW marker, the second (RBC1) and third
(RBC2) lanes are samples from two di¡erent subjects. MAPK
antibody revealed two bands of 44 and 42 kDa, corresponding
to p44ERK1 and p42ERK2.
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acid markedly increased MAPK activity (from
0.62 þ 0.13 to 3.02 þ 1.51 pmol min31 mg protein31,
P6 0.01). PD98059 (100 WM for 30 min) inhibited
okadaic stimulation (from 3.02 þ 1.51 to 1.56 þ 0.52
pmol min31 mg protein31 P6 0.01) (Fig. 5). On the
contrary, Na-depletion with nystatin and cellular
acidi¢cation did not alter MAPK activity (data not
shown).
3.2. E¡ect of MAPK activation on NHE activity
As previously reported, NHE activity was in-
creased by insulin and okadaic acid [8]. As shown
in Fig. 6, we con¢rmed that insulin (100 nM) and
okadaic acid (1 WM) enhance NHE activity from
17 þ 2 to 38 þ 9 mmol l31 cell h31, P6 0.05 and
17 þ 2 to 40 þ 7 mmol l31 cell h31, P6 0.05, respec-
tively. After incubation with PD98059 (100 WM for
30 min) the e¡ect of insulin and okadaic acid on
NHE activity was completely inhibited (Fig. 6).
4. Discussion
Our study demonstrates the presence of MAPK
isoforms p44ERK1 and p42ERK2 in human red blood
cell. These kinases were activated by insulin and oka-
daic acid. The insulin-induced MAPK activation
seems to be transient, returning to basal levels at
10 min. This e¡ect was completely abolished by
PD98059, a speci¢c inhibitor of MEK, the MAPK
activator. The activation of MAPK by insulin regu-
lates NHE activity, suggesting a possible link be-
tween insulin signaling, MAPK stimulation and
NHE-1 activity in insulin-independent red blood
cells. This pathway has been already investigated in
insulin-dependent cells.
MAPK, a family of ubiquitous Ser/Thr kinases,
plays an important role in various signal transduc-
tion pathways [13]. The activation of MAPK family
is regulated by phosphorylation of tyrosine and
threonine residues, both of which are necessary for
enzyme activity. Once activated, MAPK are respon-
sible for the phosphorylation and activation of other
downstream kinases and regulatory proteins [18]. In
particular, two members of this family, the extracel-
lular related kinases 1 (p44ERK1) and 2 (p42ERK2) are
involved in the intracellular signaling following insu-
lin stimulation [19]. Recently, it has been shown that
MAPK is involved in erythropoietin-induced di¡er-
entiation. In fact, in human erythroid-forming cells
Fig. 4. MAPK activity after insulin stimulation (100 nM for
3 min) in the absence (middle bar) and in the presence of
PD98059 (right bar). MAPK activity (mean þ S.E., n = 11) was
determined as described in Section 2. **P6 0.01 versus control
condition.
Fig. 3. Time course of MAPK activation by insulin. MAPK ac-
tivity (mean þ S.E.) was determined at baseline (0 min) and in
the presence of insulin (100 nM) for 1, 2, 3, 5 and 10 min, as
described in Section 2.
Fig. 5. MAPK activity after okadaic acid exposure in the ab-
sence (middle bar) and in the presence of PD98059 (right bar).
MAPK activity (mean þ S.E., n = 5) was determined as described
in Section 2. OA, okadaic acid. **P6 0.01 versus control con-
dition.
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erythropoietin and stem cell factor synergistically ac-
tivate p44ERK1 and p42ERK2 [20].
To our knowledge, this is the ¢rst study that docu-
ments the presence of p44ERK1 and p42ERK2 in hu-
man circulating RBC suggesting that MAPK is
present not only in staminal hematopoietic cell, but
in all the circulating elements, including RBC and
platelets [11]. Although in RBC the physiologic func-
tion of MAPK is not clear, our results suggest a
potential role of MAPK in the signal transduction
mechanisms of these cells.
Insulin receptors have been identi¢ed in human
RBC [21]. They are about 2000 per erythrocyte,
but their function is still unclear. Furthermore, the
presence of Ras, a downstream element of the insulin
receptor-activated cascade, has already been docu-
mented in human RBC [22].
Several studies have shown that p44ERK1 and
p42ERK2 are activated by insulin through a Ras-de-
pendent mechanism [19]. Ras is activated by the
translocation of Sos to the plasma membrane due
to the tyrosine-phosphorylation of Grb2 or IRS-1.
Activated Ras recruits RAF which is responsible
for phosphorylation and activation of MEK, the up-
stream kinase of the ERK cascade [23].
In the current study, we demonstrated that in
RBC, MAPK is activated by insulin. Phosphoryla-
tion of MAPK peaked at 3 min, and its activation
was inhibited by PD98059, a speci¢c MEK inhibitor,
at the concentration used in our experiments [24].
The activation of MAPK by insulin is transient,
probably due to rapid dephosphorylation of the
threonine and tyrosine residues by protein phospha-
tases. In fact, RBC contain a large amount of con-
stitutively active phosphatases [15].
Furthermore, we evaluated the e¡ect of okadaic
acid, a serine/threonine protein phosphatase inhibi-
tor, on MAPK activation. Okadaic acid induces a
marked increase of serine/threonine residue phos-
phorylation of various RBC proteins, whereas it
does not a¡ect serine/threonine^protein kinase activ-
ity [25]. We found that okadaic acid stimulates
MAPK activity whose e¡ect is completely abolished
by PD98059, suggesting that the latter does not act
directly on MAPK, but on MEK or other upstream
activators of MAPK activated by RBC phosphatases
inhibition.
It has been shown that MAPK cascade is involved
in NHE-1 regulation in eukaryotic cell [26]. Pontre-
moli et al. reported that insulin and okadaic acid
increase NHE activity in human RBC [27]. Our
data con¢rm that insulin stimulates NHE activity
in RBC. Furthermore, we demonstrate the insulin
receptor signaling cascade (i.e. phosphorylation of
p44ERK1 and p42ERK2, activation of MAPK activity,
activation of NHE) in human RBC. These e¡ects
Fig. 6. E¡ects of insulin and okadaic acid on NHE activity, with and without PD98059. NHE activity (mean þ S.E.) was determined
as described in Section 2. OA, okadaic acid. *P6 0.05 versus control conditions.
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were inhibited by PD98059, suggesting a direct link-
age between NHE activation and MAPK. MAPK
probably does not directly phosphorylate NHE-
1[2,10]. Therefore, we hypothesized the existence of
other intracellular downstream kinases, capable of
phosphorylating the NHE-1.
In conclusion, we found that MAPK isoforms
p44ERK1 and p42ERK2 play a role in the activation
of NHE-1 in human RBC following insulin stimula-
tion. This might account for the correlation between
insulin-resistance and cation heteroexchange activity
(sodium^proton and sodium^lithium exchange). Fur-
ther studies are needed to better elucidate such a
correlation which is common in patients with essen-
tial hypertension [28].
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